Publikace
- Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells2013 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamine2022 | Farmaceutická fakulta v Hradci Králové
- Structure-Activity Relationships of Nitro-Substituted Aroylhydrazone Iron Chelators with Antioxidant and Antiproliferative Activities2018 | Farmaceutická fakulta v Hradci Králové
- Intravenous rutin in rat exacerbates isoprenaline-induced cardiotoxicity likely due to intracellular oxidative stress2017 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- Design, Synthesis, and Biological Evaluation of Isothiosemicarbazones with Antimycobacterial Activity2017 | Farmaceutická fakulta v Hradci Králové
- Protective Effects of D-Penicillamine on Catecholamine-Induced Myocardial Injury2016 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové, 1. lékařská fakulta
- Aroylhydrazone iron chelators: Tuning antioxidant and antiproliferative properties by hydrazide modifications2016 | Farmaceutická fakulta v Hradci Králové
- Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products2016 | Farmaceutická fakulta v Hradci Králové
- Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injury2016 | Farmaceutická fakulta v Hradci Králové
- Synthesis and analysis of novel analogues of dexrazoxane and its open-ring hydrolysis product for protection against anthracycline cardiotoxicity in vitro and in vivo2015 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
Loading network view...